Pamela Esposito Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Pamela Esposito.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Pamela Esposito. Pamela Esposito is Chief Business Officer in Replimune Group, Inc. ($REPL) and Director in Kymera Therapeutics, Inc. ($KYMR).
Latest Insider Trading Transactions of Pamela Esposito
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | A | 31.58 | 51,250 | 1,618,475 | 51,250 | |
Apr 05 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Grant | A | 0.00 | 34,165 | 0 | 210,159 | 176 K to 210.2 K (+19.41 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.01 | 5,727 | 5,784 | 73,203 | |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.01 | 29,273 | 29,566 | 78,930 | |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.01 | 20,000 | 20,200 | 108,203 | |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 42.38 | 5,127 | 217,282 | 175,994 | 181.1 K to 176 K (-2.83 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 43.24 | 600 | 25,944 | 181,121 | 181.7 K to 181.1 K (-0.33 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.01 | 5,727 | 5,784 | 181,721 | 176 K to 181.7 K (+3.25 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 43.58 | 29,273 | 1,275,717 | 175,994 | 205.3 K to 176 K (-14.26 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.01 | 29,273 | 29,566 | 205,267 | 176 K to 205.3 K (+16.63 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 45.02 | 20,000 | 900,400 | 175,994 | 196 K to 176 K (-10.20 %) |
Jan 19 2021 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.01 | 20,000 | 20,200 | 195,994 | 176 K to 196 K (+11.36 %) |
Dec 28 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.75 | 50,704 | 88,732 | 32,758 | |
Dec 28 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.75 | 50,704 | 88,732 | 175,994 | 125.3 K to 176 K (+40.47 %) |
Dec 15 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 3.30 | 12,590 | 41,547 | 121,691 | |
Dec 15 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 3.30 | 12,590 | 41,547 | 125,290 | 112.7 K to 125.3 K (+11.17 %) |
Dec 15 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 3.30 | 12,590 | 41,547 | 121,691 | |
Dec 15 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 3.30 | 12,590 | 41,547 | 125,290 | 112.7 K to 125.3 K (+11.17 %) |
Oct 16 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.01 | 16,000 | 16,160 | 128,203 | |
Oct 16 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 35.04 | 9,000 | 315,360 | 112,700 | 121.7 K to 112.7 K (-7.40 %) |
Oct 16 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 30.15 | 7,000 | 211,050 | 121,700 | 128.7 K to 121.7 K (-5.44 %) |
Oct 16 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.01 | 16,000 | 16,160 | 128,700 | 112.7 K to 128.7 K (+14.20 %) |
Sep 09 2020 | KYMR | Kymera Therapeutic ... | Esposito Pamela | Director | Option Exercise | A | 29.55 | 40,127 | 1,185,753 | 40,127 | |
Sep 09 2020 | KYMR | Kymera Therapeutic ... | Esposito Pamela | Director | Option Exercise | A | 29.55 | 40,127 | 1,185,753 | 40,127 | |
Sep 01 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.01 | 5,000 | 5,050 | 144,203 | |
Sep 01 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Sell | S | 27.05 | 5,000 | 135,250 | 112,700 | 117.7 K to 112.7 K (-4.25 %) |
Sep 01 2020 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.01 | 5,000 | 5,050 | 117,700 | 112.7 K to 117.7 K (+4.44 %) |
Dec 23 2019 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.75 | 25,700 | 44,975 | 83,462 | |
Dec 23 2019 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.75 | 25,700 | 44,975 | 112,700 | 87 K to 112.7 K (+29.54 %) |
Apr 03 2019 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | A | 15.50 | 75,750 | 1,174,125 | 75,750 | |
Dec 17 2018 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | M | 1.75 | 87,000 | 152,250 | 109,162 | |
Dec 17 2018 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Buy | M | 1.75 | 87,000 | 152,250 | 87,000 | 0 to 87 K |
Jul 26 2018 | REPL | Replimune Group, I ... | Esposito Pamela | Chief Business Offi ... | Option Exercise | A | 15.00 | 70,000 | 1,050,000 | 70,000 |
Page: 1